`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________
`
`MSN LABORATORIES PRIVATE LTD. AND MSN PHARMACEUTICALS
`INC.
`Petitioners,
`v.
`BAUSCH HEALTH IRELAND LIMITED,
`Patent Owner.
`____________________
`
`Case No. IPR2023-00016
`U.S. Patent No. 7,041,786
`____________________
`
`PATENT OWNER’S MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2023-00016
`US. Patent No. 7,041,786
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Bausch Health Ireland
`
`Limited (“Bausch Health”) hereby submits the following mandatory notices in
`
`connection with this proceeding.
`
`I.
`
`BAUSCH HEALTH’S POWER OF ATTORNEY
`
`A Power of Attorney appointing lead and back-up counsel is being filed
`
`concurrently with these notices.
`
`I.
`
`BAUSCH HEALTH’S MANDATORY NOTICES
`
`(a)
`
`37 C.F.R. § 42.8(b)(1): Real Parties-in-Interest
`
`The real parties-in-interest for the Patent Owner are Bausch Health Ireland
`
`Limited and Salix Pharmaceuticals, Inc.
`
`(b)
`
`37 C.F.R. § 42.8(b)(2): Related Matters
`
`1. Judicial
`
`The patent challenged here, U.S. Patent 7,041,786 (“the ’786 patent”), has
`
`been asserted in the followinglitigations:
`
`
`Case Caption
`Case No.
`Court
`Bausch Health Ireland Limited and
`Salix Pharmaceuticals, Inc. v. MSN
`2:21-cv-10057 D.NJ.|April 22, 2021
`Laboratories Private and MSN
`Pharmaceuticals Inc.
`
`
`
`
`
`Case No.
`
`2:21-cv-10403
`
`Case No. IPR2023-00016
`US. Patent No. 7,041,786
`
`April 28, 2021
`(Transferred
`to N.D.
`W.Va.)
`
`from D.N.J.)
`
`Case Caption
`Bausch Health Ireland Limited and
`Salix Pharmaceuticals, Inc. v.
`Mylan Laboratories Ltd., Agila
`Specialties Inc., Mylan API US
`LLC, Mylan Inc., Viatris Inc., and
`Mylan Pharmaceuticals Inc. - A
`Viatris Company (transferred to
`N.D.W.V.)
`Bausch Health Ireland Limited and
`Salix Pharmaceuticals, Inc. v.
`Mylan Laboratories Ltd., Agila
`Specialties Inc., Mylan API US
`LLC, Mylan Inc., Viatris Inc., and
`Mylan Pharmaceuticals Inc. - A
`Viatris Compan
`Bausch Health Ireland Limited and
`Salix Pharmaceuticals, Inc. v.
`Mylan Laboratories Ltd., Agila
`Specialties Inc., Mylan API US
`LLC, Mylan Inc., Viatris Inc., and
`Mylan Pharmaceuticals Inc. - A
`Viatris Compan
`Bausch Health Ireland Limited and
`Salix Pharmaceuticals, Inc. v.
`Mylan Laboratories Ltd., Agila
`Specialties Inc., Mylan API US
`LLC, Mylan Inc., Viatris Inc., and
`Mylan Pharmaceuticals Inc. - A
`Viatris Compan
`
`1:21-cv-00611
`
`April 29, 2021
`
`2:21-cv-00573
`
`April 30, 2021
`
`1:22-cv-00020
`
`March 9, 2022
`(Transferred
`
`2. Administrative
`
`Mylan Pharmaceuticals Inc.v.
`March21,
`IPR2022-00722|7,041,786
`2022
`
`Case Caption
`
`seats
`
`pC
`
`Bausch Health Ireland Limited
`
`
`
`IPR2022-01102 9,610,321
`IPR2022-01103
`
`IPR2022-01104
`
`IPR2022-01105
`
`
`9,919,024
`
`9,925,231
`
`June 10,
`2022
`June 10,
`2022
`June 10,
`2022
`June 10,
`2022
`
`Case No. IPR2023-00016
`U.S. Patent No. 7,041,786
`
`9,616,097
`
`Mylan Pharmaceuticals Inc. v.
`Bausch Health Ireland Limited
`Mylan Pharmaceuticals Inc. v.
`Bausch Health Ireland Limited
`Mylan Pharmaceuticals Inc. v.
`Bausch Health Ireland Limited
`Mylan Pharmaceuticals Inc. v.
`Bausch Health Ireland Limited
`
`
`
`
`
`4
`
`
`
`
`
`3. Patents and Applications
`
`Case No. IPR2023-00016
`U.S. Patent No. 7,041,786
`
`The ’786 patent, filed as U.S. Patent Application No. 10/107,814, claims the
`
`benefit of the following:
`
`• U.S. Provisional Application No. 60/348,646 filed January 17, 2002,
`
`which has expired.
`
`The following are continuations of the application leading to the ’786 patent:
`
`• U.S. Application No. 11/347,115 filed February 2, 2006, which issued
`
`as U.S. Patent No. 7,799,897.
`
`• U.S. Application No. 12/763,707 filed April 20, 2010, which issued as
`
`U.S. Patent No. 8,114,831.
`
`• U.S. Application No. 13/339,785 filed December 29, 2011, which
`
`issued as U.S. Patent No. 8,637,451.
`
`• U.S. Application No. 14/137,256 filed December 20, 2013, which is
`
`abandoned.
`
`• U.S. Application No. 16/870,942, filed May 9, 2020, which is
`
`pending.
`
`37 C.F.R. § 42.8(b)(3) and (4): Lead and Back-Up Counsel, and
`(c)
`Service Information
`
`
`
`
`5
`
`
`
`Bausch Health designates the following counsel to transactall businessin the
`
`Case No. IPR2023-00016
`US. Patent No. 7,041,786
`
`United States Patent & Trademark Office associated with the above-captioned
`
`proceeding.
`
`Lead Counsel
`
`Justin J. Hasford (Reg. No. 62,180)
`justin.hasford@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4175
`Fax:
`(202) 408-4400
`
`
`
`
`
`Back-Up Counsel
`
`Bryan C. Diner (Reg. No. 32,409)
`bryan.diner@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4116
`Fax:
`(202) 408-4400
`
`Joshua L. Goldberg (Reg. No. 59,369)
`joshua.goldberg@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-6092
`Fax:
`(202) 408-4400
`
`Kassandra M.Officer (Reg. No. 74,083)
`kassandra.officer@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4270
`Fax:
`(202) 408-4400
`
`Lauren J. Robinson (Reg. No. 74,100)
`lauren.robinson@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER,L.L.P.
`
`
`
`
`
`Case No. IPR2023-00016
`U.S. Patent No. 7,041,786
`
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4426
`Fax: (202) 408-4400
`
`Caitlin E. O’Connell (Reg. No. 73,934)
`caitlin.o’connell@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4004
`Fax: (202) 408-4400
`
`Kyu Yun Kim (Reg. No. 72,783)
`kyuyun.kim@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4344
`Fax: (202) 408-4400
`
`
`Please address all correspondence regarding this proceeding to lead and back-
`
`
`
`
`
`
`
`up counsel at the addresses listed above. Bausch Health also consents to electronic
`
`service by email.
`
`Dated: November 1, 2022
`
`
`
`Respectfully submitted,
`
`
`By: /Justin J. Hasford/
`Justin J. Hasford, Reg. No. 62,180
`Lead Counsel
`Bryan C. Diner, Reg. No. 32,409
`Back-up Counsel
`7
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2023-00016
`U.S. Patent No. 7,041,786
`
`Joshua L. Goldberg, Reg. No. 59,369
`Back-up Counsel
`Kassandra M. Officer Reg. No. 74,083
`Back-up Counsel
`Lauren J. Robinson Reg. No. 74,100
`Back-up Counsel
`Caitlin E. O’Connell, Reg. No. 73,934
`Back-up Counsel
`Kyu Yun Kim, Reg. No. 72,783
`Back-up Counsel
`
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Ave. NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner
`
`
`8
`
`
`
`
`
`Case No. IPR2023-00016
`U.S. Patent No. 7,041,786
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent Owner’s
`
`Mandatory Notices Pursuant to 37 C.F.R. § 42.8 was served on November 1,
`
`2022, via email directed to counsel of record for the Petitioner at the following:
`
`Andrew O. Larsen
`Merchant & Gould, P.C.
`500 Fifth Avenue, Suite 4100
`New York, NY 10110
`alarsen@merchantgould.com
`
`Melissa Hayworth
`Merchant & Gould, P.C.
`1900 Duke, Street, Suite 600
`Alexandria, VA 22314
`mhayworth@merchantgould.com
`
`Christopher J. Sorenson
`Merchant & Gould, P.C.
`150 South Fifth Street, Suite 2200
`Minneapolis, MN 55402
`csorenson@merchantgould.com
`
`plecanatidemerchant@merchantgould.com
`
`
`
`Date: November 1, 2022
`
`
`
`
`
`
`
`
`
`
`
`/Geneva Eaddy/
`Geneva Eaddy
`Case Manager
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER LLP
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
